Emblem Corp. (fka EMMBF)

[lbcb123]

Explanation:

11/29/18* - Estimated earnings date for Q3
Q3 2018
---
-0.02 - Estimated loss per share diluted
-0.03 - Estimated loss per share
3 - Possibly 3 total analysts?
$2.3M - Consensus revenue estimate

8/28/18* - Estimated earnings date for Q2
Q2 2018
---
-0.02 - Estimated loss per share diluted
-0.03 - Estimated loss per share
3 - Possibly 3 total analysts?
$1.9M - Consensus revenue estimate

5/29/18 - Q1 earnings release date
Q1 2018
-0.03 - These three lines are loss per share (actual)
-0.02 - Loss per share diluted (actual)
-0.04 - Loss per share (estimated) Not positive which is which
3
$1.0M - Actual revenue for Q1

A "diluted" basis just means you include the number of shares as if every outstanding warrant was exercised. They have a long way to go before most warrants will be exercised above $2.

Would be nice percentage gain. More important for now is patient count. Need to have hit 4000 in Q2 to be seen as positive. Needs to be at least 5000 for Q3.